Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-512-0 | CAS number: 65140-91-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- toxicity to reproduction
- Remarks:
- other: subchronic feeding study
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study was performed similar to OECD guideline 409 and under GLP-like quality controlled conditions with QAU statement provided.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1980
Materials and methods
- Principles of method if other than guideline:
- 90 day feeding study similar to OECD 409
- GLP compliance:
- no
- Remarks:
- but with QAU statement.
Test material
- Reference substance name:
- Calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]
- EC Number:
- 265-512-0
- EC Name:
- Calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]
- Cas Number:
- 65140-91-2
- Molecular formula:
- C17 H29 O4 P. 1/2Ca
- IUPAC Name:
- calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]
- Details on test material:
- Physical appearance: white, solid powder
Constituent 1
Test animals
- Species:
- other: dog
- Strain:
- other: Beagle
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Balbeggie Kennels, Fife, Scotland
- Age at arrival: 20-22 weeks
- Weight at study initiation: 5.2-9.1 kg
- Identification: tattoo on the right hind limb
- Housing: individually housed in indoor kennels measuring 0.7 x 1.6 m and equipped with under-floor heating. Brief periods of supervised exercise were permitted daily and more extended periods of up to six hours were allowed approximately weekly, in covered outside runs.
- Diet: A moistened powdered dog diet (Laboratory Diet A from BP Nutrition Products Ltd., Witham, Essex, England) was offered as two 300 g meals given three hours apart at approximately the same times daily and any food uneaten was withdrawn the following morning.
- Acclimation period: 19 weeks without treatment before assignment to this study, an additional 15 weeks after assignment before the commencement of treatment. The replacement animal was 82 weeks old and had been held without treatment for a total of 55 weeks.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): mean daily maximum = 19°± 2°C, mean daily minimum = 13° ± 4°C
- Humidity (%): 78±8
- Photoperiod: 12 hrs dark / 12 hrs light
- Air changes: 15 per hour
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
On the first four occasions of formulation, the initial dispersal of the test substance into dry powdered diet was made by mixing the required quantity of the test substance with 100 g of diet in a Kenwood planetary mixer. Thereafter this was achieved by shaking the constituents of the admixture in a closed container and homogenising this product by passage through a grinder. This modification was adopted to minimise the generation of dust and hence possible loss of compound. The resulting pre-mix was further diluted with dry powdered diet in a Kenwood Chef planetary mixer for ten minutes followed by further dilution with diet in a Hobart A200 planetary mixer (15 minutes) to give a final pre-mix of 8800 ppm. The final admixtures for Group 3 (600 ppm) and Group 4 (2000 ppm) were achieved by diluting the required amount of pre-mix with diet in a Gardner 50L trough mixer with interrupted spiral agitator (15 minutes). The final admixture for Group 2 (200 ppm) was achieved by prediluting the required amount of pre-mix with diet in a Hobart A200 planetary mixer (ten minutes) with a final dilution with diet in the Gardner trough mixer (15 minutes). Each product, and untreated control diet, was wetted with tap water (200 mL/kg): and mixed in the Gardner trough mixer (15 minutes). At the request of the Sponsor, the mixing times were extended from 17 January 1980 (Week 12) by five minutes for each mixing procedure (excluding the wetting stage) involving the Kenwood planetary, Hobart A200 planetary and Gardner trough mixers. The final products were stored at 4°C for no more than four days and issued daily to the animal house.
DIET PREPARATION
- Rate of preparation of diet (frequency): at least every 4 days
- Storage temperature of food: 4°C - Details on mating procedure:
- no mating performed
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples of the unwetted diet (200 g of the single common pre-mix and of each test group final mix and 500 g of control diets) prepared before the commencement of treatment and for use in weeks 1, 5, 8/9, 13 and the last week of treatment were supplied to the sponsor for analysis. In addition, a further 50 g sample of each test diet was retained for at least three months in sealed polythene sachets and stored at room temperature in these laboratories pending possible future analysis as required by Section 58.113 of the Good Laboratory Practice regulations. These samples were not analysed and were eventually discarded.
- Duration of treatment / exposure:
- 7 days/week; 13 weeks
- Frequency of treatment:
- Continuous dosing with feed.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
200, 600, 2000 ppm
Basis:
nominal in diet
- Remarks:
- Doses / Concentrations:
8.5, 24.7, 84.1 mg/kg bw/day (males)
Basis:
actual ingested
- Remarks:
- Doses / Concentrations:
9.2, 28.3, 90.2 mg/kg bw/day (females)
Basis:
actual ingested
- No. of animals per sex per dose:
- 6 animals per sex and dose
- Control animals:
- yes, plain diet
Examinations
- Postmortem examinations (parental animals):
- GROSS PATHOLOGY: Yes
All animals were subjected to a detailed necropsy involving the opening of the cranial, thoracic and abdominal cavities.
ORGAN WEIGHTS
The following organs were dissected free of fat and other adjacent tissue before being weighed: Testes, Ovaries, Adrenals, Brain, Heart, Kidneys, Liver, Spleen, Thyroids. The ratio of organ weight to bodyweight was calculated in each case.
HISTOPATHOLOGY: Yes
The following tissues were examined microsopically: Testes, Epididymides, Ovaries, Uterus, Uterine cervix, Adrenals, Aorta (thoracic), Brain, Colon, Duodenum, Eyes and optic nerves, Gall bladder, Heart (auricle, ventricle, ventricular septum, Ileum, Jejunum, Kidneys, Liver, Lungs (including mainstem bronchi), Lymph nodes (axillary, cervical, mesenteric), Mammary gland (caudal, cranial), Oesophagus, Pancreas, Parathyroids, Pituitary, Prostate, Salivary glands (left), Sciatic nerve (left), Skeletal muscle (thigh), Skin (dorsum), Spinal cord (cervical region, lumbar region), Spleen, Sternum, Stomach (cardia, fundus, pyloru), Thymus, Thyroids, Tongue, Trachea, Urinary bladder.
Results and discussion
Results: P0 (first parental generation)
Details on results (P0)
Comparison of organ weights, expressed either in absolute or bodyweight-relative terms gave no indication of any differences attributable to the administration of the test substance. Specifically, reproductive organs did not show any deviations from control animals.
HISTOPATHOLOGY:
No changes to reproductive organs were detected that could be related to treatment with the test substance. Two male dogs in the highest dosage group had a unilateral juvenile epididymis and testis due to cryptorchidism.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 84.1 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: high dose
- Dose descriptor:
- NOAEL
- Effect level:
- 90.2 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: high dose
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.